IP firm HGF has appointed two patent attorneys to partner, increasing the partner group to 63 partners.
Once a genuine vaccine against COVID-19 has been announced, counterfeiters and fraudsters are likely to invest heavily in offering ineffective counterfeit versions of the vaccine online, according to Europol.
The Court of Justice of the European Union has handed down its decision in Royalty Pharma, providing highly-anticipated guidance on supplementary protection certificates.
Judging by today’s news cycle, you might think that the world of IP is quite advanced when it comes to artificial intelligence .
The COVID-19 pandemic is heightening the dangers posed by the global trade in counterfeit pharmaceutical products, according to the OECD and EUIPO.
A total of 79 vaccines and 155 drugs are currently being developed across the globe to combat COVID-19, according to statistics from the Austrian Institute for Health Technology Assessment.
The International Community of Breeders of Asexually Reproduced Ornamental and Fruit Varieties has implored countries to implement support measures for breeders amid the pandemic.
Greece has reportedly suggested that EU member states should jointly buy patent rights for COVID-19 tests and vaccines to ensure rapid distribution across the EU.
Mewburn Ellis has appointed a new life sciences-focused partner as part of a number of promotions in its IP team.
A British man has been charged with smuggling mislabelled drugs, purporting to be a treatment for those suffering from COVID-19, into the US.